The observation of a single embolization while on everolimus over a median exposure of approximately 4 years indicates that treatment was successful and suggests a need for longer-term mTOR inhibition to continue to prevent or slow tumor regrowth, preserve renal function, and reduce the need for future embolization. Here, MTOR is linked to neoplasm.